OTCMKTS:SGIOY Shionogi & Co., Ltd. Unsponsored ADR Q1 2026 Earnings Report $9.24 -0.03 (-0.32%) As of 03:58 PM Eastern ProfileEarnings HistoryForecast Shionogi & Co., Ltd. Unsponsored ADR EPS ResultsActual EPS$0.16Consensus EPS $0.14Beat/MissBeat by +$0.02One Year Ago EPSN/AShionogi & Co., Ltd. Unsponsored ADR Revenue ResultsActual Revenue$672.90 millionExpected Revenue$719.55 millionBeat/MissMissed by -$46.65 millionYoY Revenue GrowthN/AShionogi & Co., Ltd. Unsponsored ADR Announcement DetailsQuarterQ1 2026Date7/28/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsShionogi & Co., Ltd. Unsponsored ADR's next earnings date is estimated for Monday, October 26, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Shionogi & Co., Ltd. Unsponsored ADR Earnings HeadlinesShionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Stock Short Interest Rises 3,691.1%September 26 at 4:40 AM | americanbankingnews.comAll You Need to Know About Shionogi & Co. (SGIOY) Rating Upgrade to BuyFebruary 4, 2026 | msn.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.September 28 at 1:00 AM | Behind the Markets (Ad)Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exitsJanuary 20, 2026 | reuters.comYomiuri: Nobel Prize Winner, Shionogi Jointly Developing New Cancer DrugNovember 15, 2025 | marketwatch.comShionogi Weighs Making Antibiotics in US Amid Rising TariffsAugust 19, 2025 | bloomberg.comSee More Shionogi & Co., Ltd. Unsponsored ADR Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Shionogi & Co., Ltd. Unsponsored ADR? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Shionogi & Co., Ltd. Unsponsored ADR and other key companies, straight to your email. Email Address About Shionogi & Co., Ltd. Unsponsored ADRShionogi & Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, the company has built its business around drug discovery and has a particular focus on infectious diseases, including antiviral and antibacterial treatments. Shionogi’s products include Xofluza (baloxavir marboxil), an oral treatment for influenza, and Fetcroja (cefiderocol), an antibiotic used for certain difficult-to-treat bacterial infections. The company has also contributed compounds to HIV therapies, including dolutegravir, through its collaboration with ViiV Healthcare. Its research activities have also included central nervous system and pain-related medicines. Headquartered in Osaka, Shionogi serves patients and healthcare providers in Japan and international markets through its own operations, subsidiaries and commercial partnerships. The company is led by President and Chief Executive Officer Isao Teshirogi. Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)s trade in the United States under the symbol SGIOY and represent an interest in the Japanese-listed company.View Shionogi & Co., Ltd. Unsponsored ADR ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks3 Stocks Under the Microscope After Large Insider Sales3 Healthcare Stocks Showing Why the Sector Still Has Momentum2 Cybersecurity Stocks Breaking Out as AI Continues to Be a TailwindFertilizer Prices Keep Climbing: 3 Stocks Still Trading at a Discount Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
